Front. Immunol. Frontiers in Immunology Front. Immunol. 1664-3224 Frontiers Media S.A. 10.3389/fimmu.2022.1095038 Immunology Correction Corrigendum: Determination of CSF GFAP, CCN5, and vWF levels enhances the diagnostic accuracy of clinically defined MS from non-MS patients with CSF oligoclonal bands Probert Fay 1 * Yeo Tianrong 2 3 4 Zhou Yifan 2 5 6 Sealey Megan 2 Arora Siddharth 7 Palace Jacqueline 8 Claridge Timothy D. W. 1 Hillenbrand Rainer 9 Oechtering Johanna 10 Kuhle Jens 10 Leppert David 10 Anthony Daniel C. 2 * 1 Department of Chemistry, University of Oxford, Oxford, United Kingdom 2 Department of Pharmacology, University of Oxford, Oxford, United Kingdom 3 Department of Neurology, National Neuroscience Institute, Singapore, Singapore 4 Duke-National University of Singapore (NUS) Medical School, Singapore, Singapore 5 Translational Stem Cell Biology Branch, National Institutes of Health, Bethesda, MD, United States 6 Wellcome Medical Research Council (MRC) Trust Stem Cell Institute, University of Cambridge, Cambridge, United Kingdom 7 Department of Mathematics, University of Oxford, Oxford, United Kingdom 8 Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital, University of Oxford, Oxford, United Kingdom 9 Biomarker Development, Novartis Pharma AG, Basel, Switzerland 10 Neurologic Clinic and Policlinic, Multiple Sclerosis (MS) Center and Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), Departments of Clinical Research and Biomedicine, University Hospital Basel, University of Basel, Basel, Switzerland

Approved by: Frontiers Editorial Office, Frontiers Media SA, Switzerland

*Correspondence: Daniel C. Anthony, daniel.anthony@pharm.ox.ac.uk; Fay Probert, fay.probert@p harm.ox.ac.uk

This article was submitted to Multiple Sclerosis and Neuroimmunology, a section of the journal Frontiers in Immunology

 13 12 2022 2022 13 1095038 10 11 2022 11 11 2022 Copyright © 2022 Probert, Yeo, Zhou, Sealey, Arora, Palace, Claridge, Hillenbrand, Oechtering, Kuhle, Leppert and Anthony 2022 Probert, Yeo, Zhou, Sealey, Arora, Palace, Claridge, Hillenbrand, Oechtering, Kuhle, Leppert and Anthony

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

 A Corrigendum on Determination of CSF GFAP, CCN5, and vWF levels enhances the diagnostic accuracy of clinically defined MS from non-MS patients with CSF oligoclonal bands by Probert F, Yeo T, Zhou Y, Sealey M, Arora S, Palace J, Claridge TDW, Hillenbrand R, Oechtering J, Kuhle J, Leppert D and Anthony DC (2022). Front. Immunol. 12:811351. doi: 10.3389/fimmu.2021.811351 diagnosis metabolomics (OMICS) multiple sclerosis (MS) proteomics oligoclonal band biomarker

In the published article, there was an error in the Data Availability statement which was: "The datasets presented in this study can be found in online repositories. The names of the repository/repositories and accession number(s) can be found in the article/Supplementary Material". The correct Data Availability statement appears below.

Data availability statement

The datasets presented in this article are not readily available because they contain identifiable information from human subjects that cannot be shared in open access repositories for legal reasons. Anonymized data will be shared upon request from any qualified investigator. Requests should be directed to the corresponding authors.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

 Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.